REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 2 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -22.7% | 1,400 | -33.1% | 0.00% | – |
| Q2 2023 | $22,000 | +266.7% | 2,093 | +230.6% | 0.00% | – |
| Q1 2023 | $6,000 | -40.0% | 633 | -7.2% | 0.00% | – |
| Q4 2022 | $10,000 | +25.0% | 682 | +9.1% | 0.00% | – |
| Q3 2022 | $8,000 | -11.1% | 625 | 0.0% | 0.00% | – |
| Q2 2022 | $9,000 | 0.0% | 625 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -55.0% | 625 | -30.8% | 0.00% | – |
| Q4 2021 | $20,000 | -42.9% | 903 | -32.0% | 0.00% | – |
| Q3 2021 | $35,000 | -12.5% | 1,328 | +4.7% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 1,268 | -6.5% | 0.00% | – |
| Q1 2021 | $41,000 | +64.0% | 1,356 | +86.0% | 0.00% | – |
| Q4 2020 | $25,000 | +316.7% | 729 | +264.5% | 0.00% | – |
| Q3 2020 | $6,000 | +100.0% | 200 | +100.0% | 0.00% | – |
| Q2 2020 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,560,703 | $78,588,000 | 15.73% |
| MPM ASSET MANAGEMENT LLC | 2,603,089 | $79,889,000 | 15.43% |
| MPM BioImpact LLC | 2,069,749 | $63,521,000 | 7.98% |
| BVF INC/IL | 3,722,398 | $114,240,000 | 4.28% |
| StepStone Group LP | 8,721 | $268,000 | 4.12% |
| Logos Global Management LP | 900,000 | $27,621,000 | 2.70% |
| Redmile Group, LLC | 2,665,496 | $81,804,000 | 1.15% |
| Orbimed Advisors | 3,426,325 | $105,154,000 | 0.98% |
| Soleus Capital Management, L.P. | 133,324 | $4,092,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 248,100 | $7,614,000 | 0.58% |